NRx agrees to relinquish rights to experimental Covid-19 therapy in settlement with Relief Therapeutics


Radnor-based NRx Pharmaceuticals is transferring to Relief Therapeutics all the assets it previously used in the development of Zyesami.

Previous Glenmede CEO Gordon Fowler to retire; successor named
Next High Vibe, Mane is a Memphis shop/brand in the 'anything is possible' business